C&R Research (CEO Moon-Tae Yoon) announced on the 5th that it has signed a medical device clinical trial contract for Novabio's gum biocompatible filler 'Smile Line'.
Smile Line is a gum biocompatible filler developed to improve black triangles caused by loss of interdental papillae, and is characterized by the application of complex ingredients.
Through this agreement, C&R Research, in collaboration with its family-owned subsidiary Trial Informatics, will provide integrated services from the early stages of medical device development through clinical trials. Specifically, C&R Research will be responsible for all aspects of regulatory approval, including exploratory and confirmatory clinical trials, including RA consulting.
Trial Informatics' AI-based IT solutions will be utilized throughout the entire clinical trial process. This is expected to enhance the efficiency and accuracy of clinical data management and analysis, enabling systematic execution from clinical trial design to outcome analysis.
Eun-ju Lee, team leader of the medical device team at CNR Research, announced that they will advance the medical device clinical trial performance model through an integrated platform that combines IT and clinical practice.
- See more related articles
You must be logged in to post a comment.